Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
Titel:
Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors
Auteur:
Dees, E. Claire Infante, Jeffrey R. Cohen, Roger B. O’Neil, Bert H. Jones, Suzanne Mehren, Margaret von Danaee, Hadi Lee, Yih Ecsedy, Jeffrey Manfredi, Mark Galvin, Katherine Stringer, Bradley Liu, Hua Eton, Omar Fingert, Howard Burris, Howard